Original language | English (US) |
---|---|
Pages (from-to) | 175-176 |
Number of pages | 2 |
Journal | Leukemia and Lymphoma |
Volume | 49 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2008 |
Fingerprint
Neoplasm Antibodies
Salvage Therapy
B-Cell Chronic Lymphocytic Leukemia
Monoclonal Antibodies
alemtuzumab
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology
Cite this
Zent, C. S. (2008). The role of alemtuzumab in the treatment of chronic lymphocytic leukemia. Leukemia and Lymphoma, 49(2), 175-176. https://doi.org/10.1080/10428190701809206
The role of alemtuzumab in the treatment of chronic lymphocytic leukemia. / Zent, Clive S.
In: Leukemia and Lymphoma, Vol. 49, No. 2, 02.2008, p. 175-176.Research output: Contribution to journal › Article
Zent, CS 2008, 'The role of alemtuzumab in the treatment of chronic lymphocytic leukemia', Leukemia and Lymphoma, vol. 49, no. 2, pp. 175-176. https://doi.org/10.1080/10428190701809206
Zent CS. The role of alemtuzumab in the treatment of chronic lymphocytic leukemia. Leukemia and Lymphoma. 2008 Feb;49(2):175-176. https://doi.org/10.1080/10428190701809206
@article{43f4e7de5d264b0ea2809562b2c8b0b7,
title = "The role of alemtuzumab in the treatment of chronic lymphocytic leukemia",
author = "Zent, {Clive S.}",
year = "2008",
month = "2",
doi = "10.1080/10428190701809206",
language = "English (US)",
volume = "49",
pages = "175--176",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",
}
TY - JOUR
T1 - The role of alemtuzumab in the treatment of chronic lymphocytic leukemia
AU - Zent, Clive S.
PY - 2008/2
Y1 - 2008/2
UR - http://www.scopus.com/inward/record.url?scp=38849161398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38849161398&partnerID=8YFLogxK
U2 - 10.1080/10428190701809206
DO - 10.1080/10428190701809206
M3 - Article
C2 - 18231900
AN - SCOPUS:38849161398
VL - 49
SP - 175
EP - 176
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 2
ER -